NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersBusiness Wire • 01/20/22
NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye SymptomsBusiness Wire • 01/10/22
NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual ConferenceBusiness Wire • 01/04/22
DERMAdoctor's Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of AcceptanceBusiness Wire • 12/13/21
NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/13/21
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on DERMAdoctor Acquisition - Conference Call TranscriptSeeking Alpha • 09/30/21
NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctorBusiness Wire • 09/29/21
NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment ConferenceBusiness Wire • 09/08/21
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12Business Wire • 08/05/21